| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.4 |
| mRNA | AT7867 | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.054 | 0.4 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.027 | 0.4 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | -0.028 | 0.4 |
| mRNA | JNJ-26854165 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | 0.025 | 0.4 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.026 | 0.4 |